TIM-3 therapy for Alzheimer's is emerging as a groundbreaking approach that harnesses the immune system's potential to fight this devastating disease.Recent research indicates that by targeting TIM-3, a checkpoint molecule typically used to regulate immune responses in cancer therapies, we can potentially rejuvenate microglial cells in the brain.